Abstract. Sepsis is the most important predisposing cause inducing acute respiratory distress syndrome (ARDS); however, the mechanism of sepsis leading to the development of ARDS remains to be elucidated. Suppression of the mitogen-activated protein kinase (MAPK) signal by blocking the phosphorylation of Jun N-terminal kinase (JNK) and p38 in lung tissues could alleviate acute lung injury induced by sepsis. MAPK signaling may have a crucial role in development of the sepsis-induced acute lung injury. The specific inhibitors of JNK and p38 MAPK, SP600125 and SB203580, were administrated by intragastric injection 4 h before induction of ARDS after cecal ligation and puncture (CLP). Rats were sacrificed at 1, 6 or 24 h after CLP challenge. The histological evaluation, lung water content, and biochemical analysis were performed. The results revealed that the JNK and p38 MAPK inhibitor improved lung permeability, attenuated system inflammation, further alleviated the lung injury induced by sepsis. In conclusion, JNK and p38 MAPK signaling are essential for the development of ARDS following sepsis. Further studies are needed to illuminate the detailed mechanisms of JNK and p38 MAPK signaling in sepsis-induced ARDS.
Introduction
Acute respiratory distress syndrome (ARDS) is acute respiratory failure, which was the main cause of death among critically ill patients, with a mortality rate as high as 40% (1, 2) . ARDS has a close association with sepsis in the intensive care unit (ICU). Sepsis is the most common of ARDS (3), ~50% of ICU patients with sepsis also have complications with ARDS (4). Additionally, clinical research reveals that when sepsis-induced ARDS patients are compared with non-sepsis ARDS patients, greater severity of the illness and higher in-hospital mortality rates were observed (5) . However, the mechanism of the sepsis leading to the development of ARDS remains to be elucidated (6) .
Sepsis is the systematic response to infection; excessive inflammation damages the lungs leading to ARDS. Previous studies show inflammatory damage triggers a robust influx of neutrophils and monocytes to the site of tissue injury (7) , and the damaged or dead cells may trigger the inflammasome-dependent responses, then alert the innate immune system to the impending tissue damage, suggesting differing roles for inflammasomes in the development of ARDS (8) . The mitogen-activated protein kinase (MAPK) signal transduction pathways of inflammatory cells modulate a dysregulated, overly aggressive inflammatory response, which promotes the development of sepsis (9) . Inflammatory signals are initiated by the recognition of inflammatory stimuli by specific transmembrane and intracellular receptors, previous studies have found that following inflammatory stimulation, some major MAPK subfamilies, including extracellular signal-regulated kinase (ERK), p38 and Jun N-terminal kinase (JNK) were activated (10) , which induces the expression of multiple genes that together regulate the inflammatory response (11) .
Through the phosphorylation of a range of downstream substrates, different MAPKs have diverse roles in transmitting the receptor-proximal signals to the transcriptional activation of selected genes (12) . Previous studies found that MAPK Modulation of mitogen-activated protein kinase attenuates sepsis-induced acute lung injury in acute respiratory distress syndrome rats pathways may provide drug targets in inflammation to inhibit cytokine production (13, 14) . Previous studies determined that in mice with cecal ligation and puncture (CLP) the protein expression of Toll-like receptor 4 (TLR4), phosphorylated (p)-p38, p-JNK and p-ERK was increased, whereas treatment with Compound 9a protected against septic injury by suppressing MAPK-mediated inflammatory signaling (15) . In a lipopolysaccharide (LPS)-stimulated ARDS mouse model, some drugs or compounds (including Decitabine, 5-azacitidine, Andrographolide sulfonate, Hydroxy-Jolkinolide B-1 and Astilbin) alleviated LPS-induced ARDS by suppressing LPS-induced activation of the MAPK signaling pathways by blocking the phosphorylation of JNK, ERK and p38 in lung tissues (16) (17) (18) (19) . Previous studies indicated that glycyrrhizic acid and Losartan have a protective effect against sepsis-induced acute lung injury by inhibiting the inflammatory response, reducing damage from oxidative stress, and apoptosis via inactivation of JNK and p38 MAPK (20, 21) . The aforementioned studies indicated the effect of MAPK signaling, particularly the JNK and p38 MAPK on sepsis-induced ARDS. The aim of the current study was to identify the effect of MAPK signaling on sepsis-induced acute lung injury in ARDS rats, to further clarify the mechanism of sepsis leading to the development of ARDS.
Materials and methods

Animals.
A total of 72 adult male Sprague-Dawley (SD) rats (6-8 weeks old; weight, 220-270 g) were obtained from Laboratorial Animal Center of Shandong University (Jinan, China). All animals were kept in a standard environment with ~23˚C room temperature, 30-60% humidity and a 12-h light/dark cycle, allowed free access to standard rodent chow and drink, and adapted to laboratory conditions for a minimum of 3 days. The study protocols conformed to the Guide for the Care and Use of Laboratory Animals (National Institutes of Health, Bethesda, MD, USA) and were approved by the Institutional Animal Care and Use Committee of Qingdao University (Qingdao, China).
Rat model of sepsis-induced ARDS (22) . All rats were anesthetized with 10% chloral hydrate (300 mg/kg) by intra-peritoneal injection before surgical procedures with 8 h preoperative fasting food. After a 2-cm incision through midline, the cecum was carefully isolated and ligated at distal to the ileocecal valve with a 4-0 silk suture to avoid intestinal obstruction. The cecum was punctured twice with a sterile 20-gauge needle and gently squeezed to extrude a small amount of feces from the perforation sites. The quantity of extruded feces was limited (small droplet, ~1 mm in diameter) and consistent in all rats. Next, the abdominal cavity was closed in two layers with continuous suture of 3-0 silk after the cecum was returned.
In the sham group, the abdomen was opened and the cecum manipulated, but no cecal ligation or cecal puncture was performed and the abdomen was closed. Following surgery each rat received 1 ml normal saline by subcutaneous injection for fluid resuscitation and no antibiotics were administrated.
Experimental protocol. Rats were randomly divided into 6 groups according to a random number 
Hematoxylin and eosin (H&E) staining and lung injury scoring.
The right upper lobe of the lung was embedded in paraffin (Thermo Fisher Scientific, Inc.) and sectioned at 5 µm. The sections were stained with H&E (Beyotime Institute of Biotechnology). The severity of lung injury was determined as previously described (23) . Lung injury was graded from 0 (normal) to 4 (severe) for the following: Edema, alveolar and interstitial inflammation, alveolar and interstitial hemorrhage, atelectasis and hyaline membrane formation. The total lung injury score per mouse was determined as sum of the aforementioned scores. Two investigators blinded to the experimental protocol analyzed ten randomly selected high-power fields in each slide at a magnification x400.
Evaluation of the LWC. The right lower lobe of the lung from the rats was weighed immediately and subsequently dried at 80˚C for 48 h to calculate the wet/dry weight ratio (W/D). The LWC was calculated using the following formula:
Cytokine detection. Blood samples (5 ml) were collected by cardiac puncture and centrifuged at 1,500 x g for 5 min at 4˚C. The concentration of interleukin-6 (IL-6), IL-10, and tumor necrosis factor-α (TNF-α) proteins in the supernatant were detected using a commercial rat cytokine-specific enzyme-linked immunosorbent assay (ELISA) kits (cat. nos. MM-0190R1, MM-0195R1 and MM-0180R1; Jingmei Biotech, Beijing, China) following the manufacturer's protocol. All samples were tested in duplicate.
Statistical analysis. The data were presented as the mean ± standard deviation. Statistical analyses were performed using SPSS version 19.0 (IBM, Armonk, NY, USA). Comparisons among multiple groups were performed using one-way ANOVA followed by a Bonferroni's post hoc test. P<0.05 was considered to indicate a statistically significant difference.
Results
Regulation of pulmonary JNK and p38 MAPK signalling after CLP challenge. The protein expression of total JNK, total p38 MAPK, p-JNK and p38 MAPK (p-p38 MAPK) in lung tissues 1, 6, and 24 h after CLP challenge were evaluated using western blotting analysis. The p-JNK/total JNK and p-p38 MAPK/total p38 MAPK protein were increased in the sepsis-induced lung injury group (group B) compared with the shame control group (group A) (P<0.05). The p-JNK/total JNK protein was downregulated in the groups D and F compared with group B (P<0.05; Fig. 1A ) and the p-p38 MAPK/total p38 MAPK protein was downregulated in the group E and F compared with group B (P<0.05; Fig. 1B ). The same results were found when compared with the DMSO control (group C) (P<0.05; Fig. 1 ).
Effect of MAPK signalling on pulmonary histopathology of sepsis-induced acute lung injury rats. The thickening of the alveolar wall, alveolar and interstitial inflammatory cell infiltration, haemorrhaging, alveolar exudates and the edema were increased in the lung tissue of rats after sepsis-induced lung injury (group B), and the lung injury score for quantification of the lung injury was also increased compared with group A (P<0.05). However, these histopathological characteristics and the lung injury score were alleviated at 1, 6, and 24 h in the groups D, E and F compared with group B (P<0.05). The same effect was found when compared with the DMSO control (group C) (P<0.05; Fig. 2 ).
Effect of MAPK signalling in sepsis-induced lung permeability. The LWC was calculated to evaluate lung edema. LWC was significantly reduced at 1, 6, and 24 h in the groups D, E and F compared with group B (P<0.05). The same effect was found when compared with the DMSO control (group C) (P<0.05; Fig. 3 ). 
Effect of MAPK signalling on the serum levels of inflammatory factors in sepsis-induced acute lung injury rats.
The levels of the pro-inflammatory cytokines IL-6 and TNF-α and the anti-inflammatory cytokine IL-10 were measured in the serum of rats 1, 6, and 24 h after CLP challenge. Levels of all three cytokines were significantly higher at 6, and 24 h when group B is compared with group A, while IL-6 and TNF-α were increased at 1 h in group B compared with group A (P<0.05; Fig. 4 ). IL-6 and TNF-α were reduced at 1, 6, and 24 h in the groups D, E and F compared with group B (Fig. 4A  and B) , whereas IL-10 was increased (P<0.05; Fig. 4C ). The same effects were found when compared with the DMSO control (group C) (P<0.05; Fig. 4 ).
Discussion
ARDS is regarded as part of a systemic inflammatory response, particularly systemic sepsis (24) , which is usually accompanied by excessive inflammatory cell infiltration, cascade release of inflammatory factors, and extravasation of protein-rich fluid (25) . Previous studies have determined that MAPK signaling pathways may have an important pathogenic role in the inflammatory process associated with sepsis-induced ARDS (19, 26, 27) . As the current study demonstrated, ARDS triggered by sepsis after CLP challenge may induce phosphorylation of JNK and p38 MAPK in the lung tissue and modulation of MAPK signaling by JNK or/and p38 MAPK-specific inhibitor may significantly improve the pulmonary histopathology and lung permeability, increasing the serum levels of anti-inflammatory factors and reducing the serum levels of pro-inflammatory factors in sepsis-induced acute lung injury rats.
Some of MAPKs, including ERK1, ERK2, p38α, JNK1 and JNK2 have been confirmed to be involved in innate immunity (10), Germline-encoded pattern recognition recep-, Germline-encoded pattern recognition receptors (PRRs) recognize invariant microbial components, termed pathogen-associated molecular patterns and then stimulate the innate immune response after infection (28, 29) . PRRs activate both MAPK and nuclear factor-κB (NF-κB) pathways then activate the immune responses (30) . Previous studies have revealed that in sepsis-induced ARDS mice after CLP the phosphorylation of p38 MAPK, ERK, and JNK increased significantly in lung tissue (15, 21) . As the links between infl am-. As the links between infl amAs the links between infl amAs the links between inflammation and ARDS (13), another study found that SB203580, a selective p38 inhibitor inhibited TNF production (14) , and SP600125, a specific JNK inhibitor, reduced CLP-induced activation of JNK and modulated the early and late steps of the inflammatory cascade in a murine model of CLP-induced sepsis (31) . According to these fi ndings, the present study identi-. According to these findings, the present study identified a robust phosphorylation of JNK and p38 MAPK in lung tissue of sepsis-induced ARDS rats after CLP challenge. The specific JNK or p38MAPK inhibitor, SP600125 or SB203580 administered by intragastric injection may significantly reduce the phosphorylation of JNK and p38 MAPK in lung tissues. This suggested that in sepsis-induced ARDS, the JNK and p38 MAPK signalling in lung tissue were stimulated, which could be downregulated by oral administration of their specific inhibitor.
Previous studies showed that inflammatory injuries trigger a robust influx of neutrophils and monocytes to the site of tissue injury (7) and the damaged or dead cells are thought to trigger the inflammasome-dependent responses, then alert the innate immune system to the impending tissue damage (8) . Previous studies confirmed that the mechanism of some drugs, including Decitabine, 5-azacitidine, Losartan and Andrographolide sulfonate, protect lungs against injury induced by sepsis via the inhibition of the phosphorylation of the ERK, JNK and p38 MAPK, which may result in the suppression of the proinflammatory cytokine expression (16, 17, 21) . Inhibition of the p38 MAPK and JNK, but not ERK could alleviate inflammatory cell infiltration and microvascular permeability in sepsis-induced ARDS mice (32). It is possible that JNK and p38 MAPK have an important role in sepsis-induced lung injury. In the current study, lung injury after CLP increased the expression of phosphorylated JNK and p38MAPK in lung tissue and administration of the JNK and p38 MAPK inhibitor may be able to reduce the severity of lung injury in mice. The beneficial effects of the JNK and p38MAPK inhibitor achieved in this model confirmed that JNK and p38MAPK are essential for the development of ARDS after sepsis and the potential therapeutic effects of JNK and p38MAPK inhibitor in such pathological conditions were elucidated. A previous study determined that p38 MAPK activation was essential for CXCR3-mediated endothelial cell apoptosis and was associated with the increase of the leakage of protein-rich fluid and inflammatory cells in ARDS-induced lung by CLP (33) . Inhibition of LPS-induced activation of JNK, ERK, and p38MAPK pathways in lung tissues may decrease the indices of pulmonary edema, lung wet-to-dry weight ratios markedly (19) . Inhibition of the p38 MAPK and JNK, but not ERK may alleviate inflammatory cell infiltration and microvascular permeability in sepsis-induced ARDS mice (32) . All of these findings suggested that the effect of JNK and p38 MAPK on sepsis-induced lung permeability. The present study found that after JNK and p38 MAPK inhibitor administration the lung edema in ARDS rats induced by sepsis after CLP was signifi cantly improved, theresignificantly improved, thereimproved, therefore it is possible that JNK and p38 MAPK were involved the deterioration of lung permeability following sepsis.
MAPKs also have an important role in inducing cytokine production. It has been previously established that inflammatory stimuli may lead to the activation of MAPK and the transcription factor NF-κB, which mediates the expression of several pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6 which have an important role in many inflammatory disease processes (34) (35) (36) (37) . Previous studies indicated that p38 MAPK inhibitors can suppress IL-6 and TNF-α expression in monocytes and mast cells (38, 39) . Additional studies have suggested roles for p38 MAPK in the in vitro production of inflammatory factors, such as TNF-α (40), IL-6 (41), somewhat paradoxically, the anti-inflammatory factor IL-10 (42,43). A previous study determined that the suppression of the activation of the JNK and p38 MAPK would significantly reduce TNF-α content in the plasma of LPS-induced ARDS mice (44) . Another previous study revealed that berberine inhibited LPS-induced expression of proinflammatory genes including IL-1β, IL-6 via suppression of the phosphorylation of p38, JNK and ERK in peritoneal macrophages (45) . Hesperidin downregulated the LPS-induced expression of pro-inflammatory cytokines, including TNF-α, IL-1β, IL-6 and enhanced the production of anti-inflammatory IL-10, IL-4, IL-12, which may be controlled by JNK and p38 MAPK pathways (46) . Glutamine treatment inhibited phosphorylation of p38 MAPK and ERK pathways critical for cytokine release, meanwhile, significantly attenuated TNF-α and IL-6 after CLP (47) . A previous study found that the regulation of TLR4-mediated induction of TNF production is ERK1 and ERK2 independent (48) . In the present study, the JNK and p38 MAPK inhibitor was able to significantly reduce the pro-inflammatory cytokines IL-6 and TNF-α. Meanwhile, an increase the anti-inflammatory cytokine IL-10 ws observed in the serum of rats after CLP challenge. It provides the direct evidence that the JNK and p38 MAPK have an important role in the system inflammation response induced by CLP in rats. This confirmed that JNK and p38 MAPK may be essential for the development of acute lung injury induced by sepsis.
It is of note noted that the present study did not identify a difference between the group D or E (single administration of SB203580 or SP600125) and the group F (combined application of SB203580 and SP600125) on pulmonary histopathology, lung permeability and the serum levels of inflammatory factors. This suggested that there may be a common downstream pathway between JNK and p38 MAPK and further investigation is required to confirm this.
In conclusion, JNK and p38 MAPK inhibitor improved the lung permeability, attenuated system inflammation and alleviated the lung injury induced by sepsis. JNK and p38 MAPK signaling are essential for the development of ARDS following sepsis, further investigations are required to elucidate the detailed mechanisms of JNK and p38 MAPK signaling in sepsis-induced ARDS.
